Vaccines and Neurological Disease

Hsiuying       Wang

doi:10.2174/138161282543191230123014

[1] 
Hofmann C, Baur MO, Schroten H. Anti-nmda receptor encephalitis after tdap-ipv booster vaccination: Cause or coincidence? J Neurol  2011; 258(3): 500-1.
[2] 
Wang H. Anti-nmda receptor encephalitis and vaccination. Inter J Mol Sci  2017; 18(1) pii: E193
[3] 
Wang H. A protocol for investigating the association of vaccination and anti-nmda receptor encephalitis. Front Biosci  2018; 10: 229-37.
[4] 
Shim B-S, Wu W, Kyriakis CS, et al. Microrna-555 has potent antiviral properties against poliovirus. J Gen Virol  2016; 97(3): 659-68.
[5] 
Steinman L. Multiple sclerosis: a two-stage disease. Nat Immunol  2001; 2(9): 762.
[6] 
Nakashima S, Nacher JC, Song J, Akutsu T. An overview of bioinformatics methods for analyzing autism spectrum disorders. Curr Pharm Des  2019; 25(43): 4552-9.
[7] 
Lee Y, Lee BH, Yip W, Chou P, Yip B-S. Neurofilament protein as biomarker in different neurological disorder. Curr Pharm Des  2019; 25(43): 4560-9.
[8] 
Tian MYJ, Li L, Li J, Lei W, Shu X. Vaccine associated neurological adverse events: a case report and mini review of literatures. Curr Pharm Des  2019; 25(43): 4570-8.
[9] 
Wang H. Anti-nmda receptor encephalitis, vaccination and viruses. Curr Pharm Des  2019; 25(43): 4579-88.
[10] 
Taguchi YH, Turki T. Neurological disorder drug discovery from gene expression with tensor decomposition. Curr Pharm Des  2019; 25(43): 4588-99.

Rights & Permissions Print Cite

Article Metrics

5

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/138161282543191230123014	Print ISSN 1381-6128
Publisher Name Bentham Science Publisher	Online ISSN 1873-4286

Current Pharmaceutical Design

Vaccines and Neurological Disease

Related Journals

Related Books